I took a full position in XON over the past few weeks. Was communicating with a broker recently who was doing due diligence before taking a position. Here is some info I provided him:
Many collaboration agreements which show industry insiders are believers. They have broad R&D portfolio including synthetic biology, rare disease and CAR-T cancer which are both hot bio plays. Merck just signed an exclusive agreement which could result in XON receiving over $800m in milestone pays. Early stage and a likely candidate for M&A if the provide good data on trials in future.
Also heard Martine Rothblatt CEO of UTHR mention them in her interview at eMerge recently. She was very high on XON potential for disrupting health care. A couple of heavy hitters involved which could disrupt share price if they decide to exit.
Cash burn vs on hand = minimal short term dilution risk.
Intrexon Corp (NYSE:XON) was downgraded by research analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a research report issued to clients and investors on Tuesday, TheFlyOnTheWall.com reports.
Intrexon Corp (NYSE:XON) opened at 57.68 on Tuesday. Intrexon Corp has a 1-year low of $16.13 and a 1-year high of $69.45. The company’s market cap is $6.30 billion. The stock’s 50 day moving average is $54.42 and its 200 day moving average is $44.85.
Intrexon Corp (NYSE:XON) last posted its earnings results on Monday, August 10th. The company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.05. The business earned $44.90 million during the quarter, compared to analysts’ expectations of $55.93 million. Equities analysts anticipate that Intrexon Corp will post ($0.07) earnings per share for the current fiscal year.
Keep an eye on XON. They sold off much higher than most bios probably because they had been a consensus favorite of many. Once the liquidation started everyone that was selling likely included XON in their liquidation list. Today the stock was pretty strong up around 10% most of the day. Still need to ensure a bottom is in, but this one will bounce faster than most once the money starts moving back in to IBB
Under: Been on the sidelines for a bit holding (building) cash. Now that "BIGLEY" has rolled out the tax plan its time to jump in.
Dec 21, 2017 19:06:02 GMT -6
martyc: Looks like you are buying Msft again!
Dec 15, 2017 11:23:29 GMT -6
martyc: The news that Trump called Rupert to congratulate him sure seems to indicate that this is heading to approval
Dec 15, 2017 11:22:23 GMT -6
Under: DIS finally getting some traction.?
Dec 14, 2017 17:08:45 GMT -6
martyc: I took an entry level position in DIS. Will add eventually to overweight when it becomes clearer that the deal will go thru. Can't believe how well positioned they will be. 60% Hulu. 20% of content watched on NFLX they can pull. More in thread
Dec 14, 2017 11:05:16 GMT -6
Under: Great posts on $DIS
Dec 13, 2017 17:50:49 GMT -6
Under: $ROKU Citron on a war path.
Nov 28, 2017 15:11:20 GMT -6
Under: $HAS takeover bid for $MAT?
Nov 10, 2017 16:16:07 GMT -6
martyc: Not looking like the market will provide any discounted opp for SGMO. Call was just too professional and all signs indicate they are on a great path for commercialization. Happy with core but wish I had some trading shs
Nov 10, 2017 9:04:05 GMT -6
martyc: For anyone looking to find an entry point into SGMO, I'm almost hoping is sells off in next few days so I can add more. They are really clicking but the fact they haven't signed new deals might cause some to exit. Watching as I have room for trading shs
Nov 9, 2017 18:28:09 GMT -6
martyc: Been an interesting ride so far. I figured the Bears would be about this good but hoped the O wouldn't look so lame. Another building yr but still possible to get to 8-8 IMO
Nov 9, 2017 18:26:08 GMT -6
Under: whats up with your Bears this year Marty?
Nov 9, 2017 17:35:25 GMT -6
martyc: Hope you were long ROKU. I wanted to see Q first so missed out
Nov 9, 2017 7:08:53 GMT -6